Obesity and Cardiovascular Risk
Cardiovascular·MeSH: Obesity
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| BGE-102 | BioAge Labs, Inc. (BIOA) |
Frequently asked questions
How many drugs are in development for Obesity and Cardiovascular Risk?
BioSniper tracks 1 drug in development for Obesity and Cardiovascular Risk across 1 company.
How many clinical trials target Obesity and Cardiovascular Risk?
There are 2 clinical trials targeting Obesity and Cardiovascular Risk tracked by BioSniper.
Deep-dive into Obesity and Cardiovascular Risk
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis